PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
13 nov. 2020 08h00 HE
|
PMV Pharmaceuticals, Inc.
U.S. Food and Drug Administration (FDA) clearance of PMV Pharmaceutical’s investigational new drug application for its lead product candidate PC14586PMV Pharma lead product candidate PC14586 granted...
PMV Pharma Granted FDA Fast Track Designation of PC14586 for the Treatment of Advanced Cancer Patients that have Tumors with a p53 Y220C Mutation
13 oct. 2020 08h00 HE
|
PMV Pharmaceuticals, Inc.
CRANBURY, N.J., Oct. 13, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc., (Nasdaq: PMVP) a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...
PMV Pharma Announces Closing of $243.5 Million Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
29 sept. 2020 16h05 HE
|
PMV Pharmaceuticals, Inc.
CRANBURY, N.J., Sept. 29, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies...
PMV Pharma Announces Pricing of Initial Public Offering
24 sept. 2020 20h06 HE
|
PMV Pharmaceuticals, Inc.
CRANBURY, N.J., Sept. 24, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies...
PMV Pharma Appoints Laurie Stelzer to the Board of Directors and Robert Ticktin as General Counsel
08 sept. 2020 08h00 HE
|
PMV Pharmaceuticals, Inc.
CRANBURY, N. J., Sept. 08, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies...
PMV Pharma Closes $70 Million in Series D Financing
03 août 2020 08h00 HE
|
PMV Pharmaceuticals, Inc.
CRANBURY, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies...
PMV Pharma Appoints Leila Alland, M.D., as Chief Medical Officer
11 déc. 2019 08h00 HE
|
PMV Pharmaceuticals, Inc.
CRANBURY, N.J., Dec. 11, 2019 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc., a leader in the discovery and development of p53-targeted small molecule drugs for the treatment of cancer, today...